Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Cheniere Energy To Sell 31 Mln Shares At $15.10/Shr - Quick Facts

Cheniere Energy Inc. (LNG: Quote), a Houston-based energy company, has reached a definitive deal with institutional investors to sell 31.0 million common shares at a negotiated price per share of $15.10. The offering may close and settle on May 10, 2012.

The company plans to use the net proceeds from the offering of around $467.9 million to invest in Cheniere Energy Partners L.P. in exchange for equity securities anticipated to be issued in association with the financing of Cheniere Partners' proposed Sabine Pass liquefaction project.

Click here to receive FREE breaking news email alerts for Cheniere Energy Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Here is a list of interesting stocks to watch on December 19. The good news is you can skip this step. There is a next move that can make your life a lot easier. Our research team has already done the groundwork for you. All these stocks listed below and many more have been researched already, and... Shares of OvaScience Inc. (OVAS) have had a strong run in 2014, rising over 370 percent year-to-date. And that's indeed a very impressive return delivered by the fertility treatment company, which suffered a setback last year when it had to suspend a U.S. trial of its flagship fertility treatment due to regulatory concerns raised by the FDA. Nike Inc., the world's largest athletic shoes and apparel maker, said Thursday after the markets closed that its second quarter profit rose 23% from last year, helped by higher revenue and improved gross margin. The company's quarterly earnings per share also came in above analysts' expectations as did its quarterly revenue.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.